Introduction of foreign DNA into mycobacteria using a shuttle phasmid
The DOI matches its Crossref record.
Abstract
Mycobacteria are major pathogens of man and animals. There are approximately 10 million cases of tuberculosis world wide with an annual mortality of three million people. Leprosy, caused by Mycobacterium leprae, afflicts over ten million people, primarily in developing countries. M. tuberculosis and mycobacteria of the M. avium-intracellulare-scrofulaceum (MAIS) group are major opportunistic pathogens of patients with acquired immune deficiency syndrome (AIDS). M. paratuberculosis is the cause of Jöhne's disease in cattle. Yet, BCG (Bacille Calmette-Guerin), an avirulent strain of M. bovis, is the most widely used human vaccine in the world, having been administered to about 2.5 X 10(9) people since 1948 (ref. 4). BCG was highly protective against tuberculosis in England, but has been found not to be effective in preventing pulmonary tuberculosis in adults in Southern India. We have initiated studies to develop the methodology for efficient gene transfer in mycobacteria. We have constructed recombinant shuttle phasmids which are chimaeras containing mycobacteriophage DNA into which an E. coli cosmid is inserted. They can replicate in E. coli as plasmids and in mycobacteria as phages, and transfer DNA across both genera. These shuttle vectors permit for the first time the introduction of foreign DNA by infection into M. smegmatis and BCG. By introducing and ultimately expressing genes for protective antigens for a variety of pathogens, it may be possible to develop cultivatabl…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The shuttle phasmid replicates in E. coli as a plasmid and in mycobacteria as a phage (9, 11).”
From Mycobacterium smegmatis: The Vanguard of Mycobacterial Research (2023) · cites this paper as [9]
In the citing paper
“Foreign DNA was first introduced into mycobacteria in 1987 with a shuttle phasmid (9).”
From Mycobacterium smegmatis: The Vanguard of Mycobacterial Research (2023) · cites this paper as [9]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Research works printed but not linked: 1
- 1. Joint International Union Against Tuberculosis and World Health Organization Study Group Tubercle 63, 157–169 (1982). 2. Bloom, B. R. & Godal, T. Rev. infect. Dis. 5, 765–780 (1983). 3. Centers for Disease Control Morbid. Mortal, wkly. Rep. 34, 774 (1986). 4. United Nations Children's Emergency Fund (UNICEF) The State of the World's Children 131 (Oxford University Press, 1985). 5. Hart, P. D. & Sutherland, I. Br. Med. J. 2, 293–295 (1977). 6. Tuberculosis Prevention Trial, Madras Ind. J. med. Res. 72 (suppl.), 1–74 (1980). 7. Okanishi, M., Suzuki, K. & Umezawa, H. /. gen. Microbiol. 80, 389–400 (1974). 8. Hopwood, D. A. & Wright, H. M. Molec. Gen. Genet. 162, 307–317 (1978). 9. Bibb, M. J., Ward, J. M. & Hopwood, D. A. Nature 274, 398–400 (1978). 10. Crawford, J. T. & Bates, J. H. Infect. Immunity 24, 979–981 (1979). 11. Mizuguchi, Y., Fukunaga, M. & Taniguchi, H. /. Bact. 146, 656–659 (1981). 12. Meissner, P. S. & Falkinham, J. O. Ill J. Bact. 157, 669–672 (1984). 13. Labidi, A., David, H. L. & Roulland–Dussoix, D. Annls Microbiologie 136B, 209–215 (1985). 14. Brenner, S., Cesareni, G. & Karn, J. Gene 17, 27–44 (1982). 15. Suarez, J. E. & Chater, K. F. Nature 286, 527–529 (1980). 16. Timme, T. L. & Brennan, P. J. /. gen. Microbiol. 130, 2059–2066 (1984). 17. Collins, J. & Hohn, B. Proc. natn. Acad. Sci. U.S.A. 75, 4242–4246 (1978). 18. Hohn, B. & Collins, J. Gene 11, 291–298 (1980). 19. Lotte, A. et al. Adv. Tuberc. Res. 32, 107–193 (1984). 20. Hopwood, D. A. et al. In Genetic Manipulation of Streptomyces–A Laboratory Manual (John Innes Foundation, Norwich, 1985). 21. Froman, S., Will, D. W. & Bogen, E. Am. J. Public Health 44, 1326–1334 (1954). 22. Redmond, W. B. & Cater, J. C. Am. Rev. resp. Dis. 82, 781–787 (1960). 23. Udou, T., Ogawa, M. & Mizuguchi, Y. /. Bact. 151, 1035–1039 (1982). 24. Birnboim, H. C. & Doly, J. Nucleic Acids Res. 7, 1513–1525 (1979). 25. Benton, W. D. & Davis, R. W. Science 196, 180–182 (1977). 26. Southern, E. / molec. Biol. 98, 503–517 (1975). 27. Jones, W. D. Jr Tubercle, Lond. 60, 55–58 (1979). 28. Jones, W. D. Jr & Greenberg, J. /. din. Microbiol. 7, 467–469 (1978).
Cited by
Items 201–300 of 314
STEINGRUBE, V. A., Wallace, R. J., Steele, L. C., & Pang, Y. J. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.5.819 · Cited by 16
Efficient construction of unmarked recombinant mycobacteria using an improved system
Yang, F. J., Tan, Y., Liu, J., Liu, T., Wang, B., Cao, Y., Qu, Y., Lithgow, T. J., Tan, S., & Zhang, T. (2014) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2014.05.007 · Cited by 14
“Appropriate antibiotic resistance genes are required for direct selection of the subset of bacteria that have taken up the DNA materials used for constructing recombinant mycobacteria, such as plasmids, cosmids and phasmids (Jacobs et al., 1987).”
BackgroundDrug discovery in tuberculosis: a molecular approach.
Mitra, P. (2012) · PubMed · Cited by 15
Bloom, B. R., & Jacobs, W. R. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb27366.x · Cited by 15
Self-citationThe next wave of recombinant and synthetic anticancer vaccines
Irvine, K. R., & Restifo, N. P. (1995) · Seminars in Cancer Biology · doi:10.1016/1044-579x(95)90003-9 · Cited by 15
Hatfull, G. F. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2523344122 · Cited by 20
“First, are the shuttle phasmids developed by Dr. Bill Jacobs Jr. and his colleagues, in which chimeric phages are constructed for efficient delivery of transposons, reporter genes, and allelic exchange substrates ( 54 – 57 ).”
Matsumoto, S. (1996) · Vaccine · doi:10.1016/0264-410x(95)00131-j · Cited by 14
Development of a BCG Recombinant Vehicle for Candidate AIDS Vaccines
Aldovini, A., & Young, R. A. (1990) · International Reviews of Immunology · doi:10.3109/08830189009061766 · Cited by 17
Recombinant Mycobacterium smegmatis vaccine candidates
Faludi, I., Szabó, Á., Burián, K., Endrész, V., & Miczák, A. (2011) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/amicr.58.2011.1.2 · Cited by 16
PHIRE and TWiV: Experiences in Bringing Virology to New Audiences
Hatfull, G. F., & Racaniello, V. R. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085449 · Cited by 13
Ozeki, Y., Igarashi, M., Doe, M., Tamaru, A., Kinoshita, N., Ogura, Y., Iwamoto, T., Sawa, R., Umekita, M., Enany, S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141658 · Cited by 13
Identification of Virulence Determinants in Pathogenic Mycobacteria
Clark‐Curtiss, J. E. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-80451-9_4 · Cited by 14
Timm, J., Rompaey, I. V., Tricot, C., Massaer, M., Haeseleer, F., Fauconnier, A., Stalon, V., Bollen, A., & Jacobs, P. (1992) · Molecular and General Genetics MGG · doi:10.1007/bf00538708 · Cited by 13
Mycobacteriophages and Tuberculosis
Hatfull, G. F. (2004) · Wiley eBooks · doi:10.1128/9781555817657.ch14 · Cited by 16
A broad-range of recombination cloning vectors in mycobacteria
Sun, J., Lau, A., Wang, X., Liao, T.-Y. A., Zoubeidi, A., & Hmama, Z. (2009) · Plasmid · doi:10.1016/j.plasmid.2009.07.003 · Cited by 12
“For years, researchers in the TB field relied on using cloning methods in which DNA inserts are outfitted with restriction sites to make them compatible with mycobacteria–Escherichia coli shuttle vectors derived from mycobacteriophage based expression systems (Jacobs et al., 1987).”
Low temperature protocol for efficient transformation ofMycobacterium smegmatis spheroplasts
Naser, S. A., McCarthy, C. M., Smith, G. B., & Tupponce, A. K. (1993) · Current Microbiology · doi:10.1007/bf01576013 · Cited by 14
“[4] reported 103-104 transfectants/ /~g DNA from the virulent D29 mycobacteriophage, but did not report the number of spheroplasts treated; nor was the frequency reported for wildtype TM4 mycobacteriophage DNA.”
BackgroundMethodZheng, C., Xie, P., & Chen, Y. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00382-6 · Cited by 12
“pox viruses and Salmonella) to produce heterologous antigens protective against tuberculosis, the live attenuated BCG vaccine also offers considerable advantages for development as a multivalent vaccine vehicle for other human pathogens [24].”
BackgroundMolecular biology: New hopes and challenges
Grange, J. M. (1988) · Tubercle · doi:10.1016/0041-3879(88)90034-7 · Cited by 12
2. The microbiology of Mycobacterium leprae; progress in the last 30 years
Colston, M. J. (1993) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(93)90064-w · Cited by 11
Genetic vaccines — a revolution in vaccinology?
Xiang, Z. Q., Pasquini, S., He, Z., Deng, H., Wang, Y., Blaszczyk‐Thurin, M., & Ertl, H. C. J. (1997) · Springer Seminars in Immunopathology · doi:10.1007/bf00870273 · Cited by 11
Respirable Bacteriophage Aerosols for the Prevention and Treatment of Tuberculosis
Hatfull, G. F., & Vehring, R. (2016) · Wiley eBooks · doi:10.1002/9781118943182.ch14 · Cited by 14
Functional analysis of pAL5000 plasmid in Mycobacterium fortuitum
Villar, C. A., & Benitez, J. (1992) · Plasmid · doi:10.1016/0147-619x(92)90047-e · Cited by 12
Live bacterial vectors for mucosal immunization
Lintermans, P. F., & Greve, H. D. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00051-8 · Cited by 10
Characterisation of plasmids extracted from AIDS—associated mycobacterium avium isolates
Morris, S. L., Rouse, D. A., Malik, A., Chaparas, S. D., & Witebsky, F. G. (1990) · Tubercle · doi:10.1016/0041-3879(90)90073-h · Cited by 10
Genome synthesis, assembly, and rebooting of therapeutically useful high G+C% mycobacteriophages
Ko, C., Sikkema, A. P., Lauer, M. J., Amarh, E. D., Garlena, R. A., Russell, D. A., Chew, N., Li, T., Harrison, I. M., Ellefson, J. W., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2523871122 · Cited by 12
“However, engineering of lytic phages can be challenging, typically requiring either construction of shuttle phasmids ( 10 , 11 ) or electroporation of phage genomic DNA and DNA substrates into recombineering strains, followed by selection and screening for the desired engineered progeny ( 12 – 14 ).”
Development of rapid microwave-mediated and low-temperature bacterial transformations
Tripp, V. T., Maza, J. C., & Young, D. D. (2013) · Journal of Chemical Biology · doi:10.1007/s12154-013-0095-4 · Cited by 10
Worachart Sirawaraporn, A., Rachada Sirawaraporn, A., Chanpongsri, A., Jacobs, W. R., & Santi, D. V. (1991) · Experimental Parasitology · doi:10.1016/0014-4894(91)90136-k · Cited by 9
Self-citationThe genetic proteome: Using genetics to inform the proteome of mycobacterial pathogens
Nicholson, K. R., Mousseau, C. B., Champion, M. M., & Champion, P. A. D. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009124 · Cited by 8
Phylogenetic relationships and codon usage bias amongst cluster K mycobacteriophages
Crane, A. E., Versoza, C. J., Hua, T., Kapoor, R., Lloyd, L., Mehta, R., Menolascino, J., Morais, A., Munig, S., Patel, Z., et al. (2021) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkab291 · Cited by 9
Lytic Efficiency of Mycobacteriophages
Hassan, S., Dusthackeer, A., Subramanyam, B., Ponnuraja, C., Sivaramakrishnan, G. N., & Kumar, V. (2010) · The Open Systems Biology Journal · doi:10.2174/1876392801003010021 · Cited by 9
“Its genome is approximately 50 kb in length and contains cohesive termini [9, 10].”
BackgroundInstability of the morpholine‐degradative phenotype in mycobacteria isolated from activated sludge
Brown, V. R., Knapp, J. S., & Heritage, J. C. (1990) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1990.tb02911.x · Cited by 9
Lazraq, R., Clavel-Sérès, S., & David, H. L. (1991) · Current Microbiology · doi:10.1007/bf02106206 · Cited by 9
“[7], who described a phasmid; however, the bacteriophage DNA eventually led to the recipient cells lysis; the same group recently described an M.”
BackgroundGhosh, S., Shaw, R., Sarkar, A., & GUPTA, S. K. (2020) · FEMS Microbiology Letters · doi:10.1093/femsle/fnaa176 · Cited by 8
Falkinham, J. O., & Crawford, J. T. (2014) · ASM Press eBooks · doi:10.1128/9781555818357.ch13 · Cited by 9
Tullius, M. V., & Horwitz, M. A. (2010) · Springer eBooks · doi:10.1007/978-3-0346-0277-8_6 · Cited by 8
Rahlwes, K. C., Osman, S. H., & Morita, Y. S. (2020) · mSphere · doi:10.1128/msphere.01039-20 · Cited by 8
“heat shock protein 60 (HSP60) promoter (28).”
Effect of IS900 Gene of Mycobacterium paratuberculosis on Mycobacterium smegmatis
Naser, S. A., Gillespie, R. F., Naser, N. A., & El-Zaatari, F. A. (1998) · Current Microbiology · doi:10.1007/s002849900396 · Cited by 11
“M. smegmatis mc2155 cells were prepared for electroporation as described by Jacobs et al [12].”
MethodInfluentialZhang, Y., & Jacobs, W. R. (2008) · Wiley eBooks · doi:10.1002/9783527611614.ch15 · Cited by 16
Self-citationKlimowicz, A. K., Garcia, E. M., Jefferson, K. K., & Dillard, J. P. (2025) · Infection and Immunity · doi:10.1128/iai.00299-25 · Cited by 8
Xue, Q., Dai, J., Li, X., Zhu, W., Si, C., & Chen, T. (2014) · Journal of Medical Virology · doi:10.1002/jmv.23901 · Cited by 6
“Single colonies were selected from a kanamycincontaining plate and then cultured overnight at 37 ̊C [Jacobs et al., 1987].”
MethodThe α1β1 region is crucial for biofilm enhancement activity of MTC 28 in Mycobacterium smegmatis
Kundu, P., Dutta, D., & Das, A. K. (2017) · FEBS Letters · doi:10.1002/1873-3468.12823 · Cited by 6
Colston, M. J. (1991) · Nature · doi:10.1038/351442d0 · Cited by 6
Gene Transfer, Gram‐Positive Bacteria
Bagyan, I., & Cutting, S. M. (1999) · Wiley eBooks · doi:10.1002/0471250589.ebt104 · Cited by 6
Flexner, C. W. (1990) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60339-7 · Cited by 6
Conventional and Contemporary Bacterial Veterinary Vaccines
Hodgson, A. L. M., & Radford, A. J. (1993) · Progress in vaccinology · doi:10.1007/978-1-4613-9226-2_8 · Cited by 5
Growth of recombinant Mycobacterium tuberculosis H37Ra in mouse macrophages
Falcone, V., & Collins, F. M. (1997) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1997.4201314.x · Cited by 5
Progress Towards a New Tuberculosis Vaccine
Lowrie, D. B., Silva, C. L., & Tascon, R. E. (1998) · BioDrugs · doi:10.2165/00063030-199810030-00004 · Cited by 5
Techniques for genetic engineering in mycobacteria
Hermans, J., & de Bont, J. A. M. (1996) · Antonie van Leeuwenhoek · doi:10.1007/bf00399613 · Cited by 5
The molecular basis of mycobacterial infection
Colston, M. J. (1996) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(96)00002-7 · Cited by 7
Chen, B., Weisbrod, T. R., Hsu, T., Sambandamurthy, V. K., Vieira-Cruz, D., Chibbaro, A., Ghidoni, D., Kile, T., Barkley, W. E., Vilchèze, C., et al. (2011) · Applied Biosafety · doi:10.1177/153567601101600302 · Cited by 4
“*Correspondence should be addressed to William R. Jacobs, Jr. at jacobsw@hhmi.org.”
BackgroundSelf-citationNascimento, L. V., dos Santos, C. C., Leite, L. C. C., & Nascimento, I. P. (2020) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760190347 · Cited by 4
“Accepted 13 April 2020 terium smegmatis and BCG.(11) This opened the possibility for development of multi-vaccines based on BCG as a live vehicle to present heterologous antigens from different pathogens.”
BackgroundInfluentialIsolation and Characterization of vB_MsmS_Celfi: A New Mycobacterium tuberculosis Bacteriophage
Payaslián, F., Gradaschi, V., Rondón, L., Dieterle, M. E., Urdániz, E., Paola, M. D., Cárcamo, J. P., Zon, F., Sosa, E. J., Porto, D. F. D., et al. (2020) · PHAGE · doi:10.1089/phage.2020.0030 · Cited by 5
Mécanismes d’action et de résistance de l’isoniazide, un antituberculeux de première ligne
Brossier, F. (2011) · Journal des Anti-infectieux · doi:10.1016/j.antinf.2011.10.003 · Cited by 7
Identification of a new antiphage system in Mycobacterium phage ButtersPreprint
Mohammed, H. T., Mageeney, C. M., & Ware, V. C. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.03.522681 · Cited by 6
Das, K., Garnica, O., & Dhandayuthapani, S. (2019) · Tuberculosis · doi:10.1016/j.tube.2019.04.007 · Cited by 3
Bacteriophages in the fish mucosa: updates on their biology, interactions, and applications
Leonora, F. H. S. V., Boonyarat, V. D. S., Pugoy, J. J., Chiong, A. E. S., Polido, M. A., & Caipang, C. M. A. (2024) · Biologia · doi:10.1007/s11756-024-01646-0 · Cited by 3
“However, a breakthrough in the late 1980s showed that mycobacterio-phage DNA could be taken up by mycobacterial spheroplasts (Jacobs et al. 1987), forming plaques and infectious units.”
Plasmids as Genetic Tools for Study of Bacterial Gene Function
Phillips, G. J. (2014) · ASM Press eBooks · doi:10.1128/9781555817732.ch28 · Cited by 3
Hughes, H. P. A., & Babiuk, L. A. (1994) · Springer eBooks · doi:10.1007/978-1-4899-1450-7_6 · Cited by 4
Recombineering in mycobacteria using mycobacteriophage proteins
Kessel, V., & Catherine, J. (2008) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 3
Alexander, D. C., & Liu, J. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-152-9_9 · Cited by 6
Molecular Biology of Mycobacterium Tuberculosis
Shinnick, T. M. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5987-0_3 · Cited by 3
Adaptive Evolution of the Mycobacterium tuberculosis Complex to Different Hosts
Broset, E., & Gonzalo‐Asensio, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-799942-5.00023-8 · Cited by 2
Luo, Y., Henning, J., & Michael, A. (2011) · InTech eBooks · doi:10.5772/22142 · Cited by 3
“As early as in the 1980s, studies showed that mycobacteria were capable of delivering foreign genes that were introduced into the microbes (Jacobs et al., 1987; Snapper et al., 1988).”
ResultHatfull, G. F. (2019) · ASM Press eBooks · doi:10.1128/9781683670131.ch63 · Cited by 2
Zheng, C., Xie, P., & Chen, Y. (2003) · Journal of Eukaryotic Microbiology · doi:10.1111/j.1550-7408.2003.tb00249.x · Cited by 2
“…live attenuated vaccines (e.g. pox viruses and Salmonella), to produce heterologous antigens protective against tuberculosis; the live attenuated strain BCG vaccine also offers considerable advantages for development as a multivalent vaccine vehicle for other human pathogens (Jacobs et al. 1987).”
BackgroundMycobacteriophages: Pathogenesis and Applications
Hatfull, G. F. (2014) · ASM Press eBooks · doi:10.1128/9781555816506.ch12 · Cited by 2
Coene, M., Kesel, M. D., Hong, N. T. T., Gheysen, A., Jezierska-Anczuków, A., & COCITO, C. G. (1993) · Archives of Virology · doi:10.1007/bf01309742 · Cited by 2
“The use of a mycobacteriophage as a vector for mycobacterial genes has been recently described (Jacobs etal. [ 11 ]; Snapper etal.”
MethodLow dose BCG vaccination in mice : immune responses and implications for tuberculosis control
Kiros, T. G. G. (2007) · University Library - University of Saskatchewan (University of Saskatchewan) · Cited by 3
Recombinant BCG as Vector for Mucosal Immunity
Langermann, S. (1996) · Elsevier eBooks · doi:10.1016/b978-012410580-5/50010-8 · Cited by 2
Heat Shock Proteins and Mycobacterial Infection
Young, D., Garbe, T. R., & Lathigra, R. B. (1991) · Springer eBooks · doi:10.1007/978-3-642-76679-4_22 · Cited by 2
Therapeutic Potential of Bacteriophage-derived ProteinsPreprint
Dicks, L. M. T., & Vermeulen, W. (2023) · Preprints.org · doi:10.20944/preprints202310.2086.v1 · Cited by 1
Prospects for designing new generation anti-tuberculosis vaccines
Tatkov, S., Дейнеко, Е. В., & Furman, D. P. (2011) · Russian Journal of Genetics Applied Research · doi:10.1134/s2079059711040071 · Cited by 1
Gene manipulation in mycobacteria
Koníčék, J., Koníčková-Radochová, M., & Šlosárek, M. (1991) · Folia Microbiologica · doi:10.1007/bf02884059 · Cited by 1
The genetics ofMycobacterium tuberculosis
Vijaya, S. (1998) · Journal of Genetics · doi:10.1007/bf02966598 · Cited by 1
Construction of Novel Live Genetically Modified BCG Vaccine Candidates Using Recombineering Tools
Flores‐Valdez, M. A., & Aceves-Sánchez, M. D. J. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1884-4_19 · Cited by 1
Genetic vaccination against tuberculosis
Lowrie, D. B., Silva, C. L., & Tascon, R. E. (1998) · Principles and practice · doi:10.1007/978-3-642-46867-4_7 · Cited by 1
Seral, J. C., Crespo-Yuste, E., Mendoza-Losana, A., & Gonzalo‐Asensio, J. (2024) · Springer eBooks · doi:10.1007/978-3-031-65986-7_2 · Cited by 1
Profile of William R. Jacobs, Jr.
Griswold, A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407879111 · Cited by 1
The role of BCG vaccine in tuberculosis control
Gheorghiu, M. (1990) · The Indian Journal of Pediatrics · doi:10.1007/bf02728707 · Cited by 1
Bacteriophage Discovery and Genomics
Hatfull, G. F. (2017) · Springer eBooks · doi:10.1007/978-3-319-40598-8_6-1 · Cited by 1
The Silent Plague: Regulation of Latent Tuberculosis Infections
Behinaein, P., & Cirillo, J. D. (2019) · Springer eBooks · doi:10.1007/978-3-030-25381-3_2 · Cited by 1
Bacteriophage Discovery and Genomics
Hatfull, G. F. (2021) · Springer eBooks · doi:10.1007/978-3-319-41986-2_6 · Cited by 1
What can Mycobacteriophages Tell Us About Mycobacterium tuberculosis?
Hatfull, G. F. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-569-5_8 · Cited by 1
Insights into Immunoregulation and Pathogenesis from a Third World Disease
Bloom, B. R., Salgame, P. R., Chan, J., Mehra, V. L., Snapper, S. B., Fan, X., Modlin, R. L., Rea, T. H., Brenner, M. B., Brennan, P. J., et al. (1989) · Springer eBooks · doi:10.1007/978-3-642-83755-5_129 · Cited by 1
Self-citationSchneider, C. Z. (2007) · Americanae (AECID Library) · Cited by 1
Vaccines for Ovarian Carcinoma
Butts, C. L., & Freedman, R. S. (1999) · Cancer Control · doi:10.1177/107327489900600402 · Cited by 1
“Other early vaccines were made from inactivated whole bacterial or attenuated viruses.(18,19) Viral pathogens were attenuated by growing them under conditions that caused them to mutate, which also prevented them from inducing a pathologic response in the human host.”
BackgroundSchroeder, L., & von Cramon‐Taubadel, N. (2020) · Wiley eBooks · doi:10.1002/9780470015902.a0028134 · Cited by 1
Ralphs, N. T., Boulnois, G. J., & Andrew, P. W. (1992) · Springer eBooks · doi:10.1007/978-94-011-1530-8_4 · Cited by 1
Genetically Engineered Human Immunodeficiency Virus Type 1 (HIV-1) Vaccines
Rovinski, B., & Klein, M. H. (1994) · Springer eBooks · doi:10.1007/978-1-4899-1450-7_10 · Cited by 1
Characterization of the role of the Rpf motif in mycobacteriophage tape measure proteins
Marinelli, L. J. (2008) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
9 Genetic Methods in Mycobacteria
Hatfull, G. F. (1999) · Methods in microbiology · doi:10.1016/s0580-9517(08)70120-x
Vaccine Design and Vaccination
McMullan, N. (2012) · doi:10.1002/9781119967309.ch13
Bjorvatn, B., & Helland, D. E. (1990) · Scandinavian Journal of Infectious Diseases · doi:10.3109/inf.1990.22.suppl-76.01
Chacón, O., Realpe, T., Barletta, R. G., & Robledo, J. (2004) · Biomédica · doi:10.7705/biomedica.v24isupp1.1316 · Cited by 2
Mbele, P. (2011) · Open University of Cape Town (University of Cape Town)
The evolutionary selective pressures exerted on A3 actinobacteriophages
Weeks‐Galindo, C. (2015) · JMU Scholoraly Commons (James Madison University)
Molecular Approaches to Developing a Vaccine for Leprosy
Mehra, V. L., Modlin, R. L., Rea, T. H., Jacobs, W. R., Snapper, S. B., Convit, J., & Bloom, B. R. (1989) · Progress in vaccinology · doi:10.1007/978-1-4612-3508-8_31
Self-citationExpressão de antígenos de Schistosoma mansoni em BCG recombinante.
Kanno, A. I. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.87.2013.tde-14052014-095103 · Cited by 2
Metadata
- Authors
- Jacobs, W. R., Tuckman, M., & Bloom, B. R.
- Affiliations
- Albert Einstein College of Medicine (US)
- Venue
- Nature
- Published
- 1987-06-11
- Volume
- 327
- Issue
- 6122
- Pages
- 532-535
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2045944193
- Cited by
- 314
- References
- 0
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 7 · 2022: 2 · 2021: 8 · 2020: 12 · 2019: 7 · 2018: 3 · 2017: 4 · 2016: 5 · 2015: 7 · 2014: 17 · 2013: 7 · 2012: 10
- FWCI
- 14.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Keywords
- mycobacteria, shuttle vector, gene transfer, Mycobacterium smegmatis, BCG, recombinant phage, protective antigen, tuberculosis, leprosy, Mycobacterium avium subsp. paratuberculosis
- MeSH terms
- Bacteriophages, Cloning, Molecular, DNA Replication, DNA, Bacterial, DNA, Recombinant, Genetic Engineering, Genetic Vectors, Mycobacterium, Plasmids, Transfection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.